Regression of Kaposi’s Sarcoma after Anti-
Tuberculous Therapy In A HIV-Negative Case With
Disseminated Tuberculosis
Volume 4 - Issue 4
Ko Chang1,2,3,4, Wei-Ru Lin1,2, Po-Chih Chen1,5,6 and Jih-Jin Tsai*1,2,3
-
Author Information
Open or Close
- 1Tropical Medicine Center,Kaohsiung Medical University Hospital, Taiwan
- 2Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Medical University Hospital, Taiwan
- 3School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
- 4Department of Internal Medicine, Kaohsiung Municipal Siao-Kang Hospital, Kaohsiung, Taiwan
- 5Department of Medical Laboratory Science and Biotechnology, College of Health Sciences, Kaohsiung Medical University, Taiwan
- 6Department of Laboratory Medicine, Kaohsiung Medical University Hospital, Taiwan
*Corresponding author:
Jih Jin Tsai, Division of Infectious diseases, Department of Internal Medicine, Kaohsiung Medical University Hospital, 100
Tzyou 1st Road, Kaohsiung 807, Taiwan
Received: April 11, 2018; Published: May 17,2018
DOI: 10.26717/BJSTR.2018.04.001084
Full Text
PDF
To view the Full Article Peer-reviewed Article PDF
Abstract
Although Kaposi sarcoma occurs in immune compromised patients, including Human Immunodeficiency Virus (HIV) infection patients,
Kaposi sarcoma associated with disseminated tuberculosis has rarely been reported on. We present a case of Kaposi sarcoma that developed
in an HIV-negative patient with disseminated tuberculosis. The Kaposi sarcoma completely regressed with antituberculous therapy without
the institution of any chemotherapy, radiotherapy or surgery. The patient remained disease-free after a long-term follow-up over five years.
Abstract|
Case Report|
Discussion|
References|